Evidence map›Paper›PMID 41596295›Full record

ReviewInternational journal of molecular sciences2026

Kazuyuki Matsushita, Kouichi Kitamura, Nobuko Tanaka, Sohei Kobayashi, Yusuke Suenaga, Tyuji Hoshino

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kazuyuki MatsushitaDepartment of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan.ORCID 0000-0001-6742-0761
Kouichi KitamuraDepartment of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan.
Nobuko TanakaDepartment of Laboratory Medicine, Chiba University Hospital, Chiba 260-8677, Japan.
Sohei KobayashiDepartment of Medical Technology and Sciences, Health and Sciences, International University of Health and Welfare, Chiba 286-8686, Japan.ORCID 0000-0002-6152-177X
Yusuke SuenagaLaboratory of Evolutionary Oncology, Chiba Cancer Center Research Institute, Chiba 260-8717, Japan.ORCID 0000-0001-6902-5386
Tyuji HoshinoDepartment of Molecular Design, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disease-specific diversity in RNA transcripts stems from RNA splicing, ribosomal abnormalities, and other factors. However, the mechanisms underlying the regulation of rRNA expression in the nucleolus and mRNA expression in the cytoplasm during cancer and neuronal differentiation remain largely unknown. In this article, we review current knowledge and discuss the regulatory mechanisms of rRNA and mRNA expression in human diseases using the splicing model of PUF60 (poly(U) binding splicing factor 60)-also known as

Indexed as

Repressor ProteinsRNA-Binding ProteinsRNA SplicingRNA Splicing FactorsAnimalsHumansNeoplasmsRNA, MessengerRNA, Ribosomalpoly-U binding splicing factor 60KDaRepressor ProteinsRNA-Binding ProteinsRNA, MessengerRNA, RibosomalRNA Splicing Factorscancerc-MycFIR/PUF60mRNArare diseaseRNA splicingrRNA

Identifiers

PMID41596295
PMCPMC12841381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.